Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
暂无分享，去创建一个
A. Camm | L. Mantovani | J. Stȩpińska | A. Turpie | F. Cools | F. Verheugt | J. Bassand | Y. Koretsune | K. Pieper | A. Kakkar | R. Corbalán | H. Gibbs | J. Steffel | P. Angchaisuksiri | S. Haas | T. Lim | H. Ragy | J. Sawhney | F. Misselwitz | B. Jacobson | S. Virdone | E. Panchenko | B. Jacobson | Garfield-Af Investigators